Voiding Disorders Clinical Trial
Official title:
Urodynamically Age-specific Prevalence of Detrusor Underactivity and Bladder Outlet Obstruction in Female Voiding Dysfunction Without Cystocele
Verified date | August 2019 |
Source | National Taiwan University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Women with symptoms of voiding dysfunction may be associated with detrusor underactivity (DU) or bladder outlet obstruction (BOO). The treatment strategies are different between DU and BOO. In general, urodynamic/videourodynamic studies are important for differential diagnosis. However, urodynamic/videourodynamic studies are invasive. The investigators are interested in whether there were specific symptoms or measurements that can be used for initial differential diagnosis between DU and BOO. Thus, the aim of this study was to elucidate the prevalence of DU and BOO in each age group and elucidate the clinical and urodynamic differences between the DU, BOO and non-DU/BOO groups.
Status | Completed |
Enrollment | 602 |
Est. completion date | September 30, 2018 |
Est. primary completion date | September 30, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Women with symptoms of voiding dysfunction. Exclusion Criteria: - Cystocele - Those women who have no complete data of maximum flow rate (Qmax), voided volume, post void residual volume (PVR) and detrusor pressure at maximum flow rate (PdetQmax) were excluded from this study. |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Taiwan University Hospital | Taipei |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital |
Taiwan,
Choi YS, Kim JC, Lee KS, Seo JT, Kim HJ, Yoo TK, Lee JB, Choo MS, Lee JG, Lee JY. Analysis of female voiding dysfunction: a prospective, multi-center study. Int Urol Nephrol. 2013 Aug;45(4):989-94. doi: 10.1007/s11255-013-0475-2. Epub 2013 May 31. — View Citation
Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic — View Citation
Hsiao SM, Lin HH, Kuo HC. Videourodynamic Studies of Women with Voiding Dysfunction. Sci Rep. 2017 Jul 28;7(1):6845. doi: 10.1038/s41598-017-07163-2. — View Citation
Karmakar D, Sharma JB. Current concepts in voiding dysfunction and dysfunctional voiding: A review from a urogynaecologist's perspective. J Midlife Health. 2014 Jul;5(3):104-10. doi: 10.4103/0976-7800.141185. Review. Retraction in: J Midlife Health. 2018 — View Citation
Lukacz ES, DuHamel E, Menefee SA, Luber KM. Elevated postvoid residual in women with pelvic floor disorders: prevalence and associated risk factors. Int Urogynecol J Pelvic Floor Dysfunct. 2007 Apr;18(4):397-400. Epub 2006 Jun 28. — View Citation
Milleman M, Langenstroer P, Guralnick ML. Post-void residual urine volume in women with overactive bladder symptoms. J Urol. 2004 Nov;172(5 Pt 1):1911-4. — View Citation
Robinson D, Staskin D, Laterza RM, Koelbl H. Defining female voiding dysfunction: ICI-RS 2011. Neurourol Urodyn. 2012 Mar;31(3):313-6. doi: 10.1002/nau.22213. Epub 2012 Mar 13. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants with Detrusor underactivity or Bladder outlet obstruction | The DU was defined when the PdetQmax was less than 20 cmH2O, the Qmax was less than 15 mL/s, and the bladder voiding efficiency (BVE) was less than 90 %. The BOO was defined when the PdetQmax was not less than 40 cmH2O, and the Qmax was less than 12 mL/s. BVE = voided volume / (voided volume+ PVR) x 100%. | Between April 1996 and September 2018 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04010656 -
Optimization of Spontaneous Postoperative Trial of Void Among Women
|
N/A | |
Enrolling by invitation |
NCT05537272 -
The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy
|
Phase 4 | |
Recruiting |
NCT06070675 -
Comparison of a Paper and Automated Bladder Diary in Pediatric Patients
|
N/A | |
Completed |
NCT03141372 -
Urinary Retention After Total Laparoscopic Hysterectomy With Immediate Foley Catheter Removal Versus Backfill Void Trial
|
N/A | |
Completed |
NCT03373773 -
Home vs. Office Foley Catheter Removal in Women With Voiding Difficulty Following Pelvic Reconstructive Surgery
|
N/A | |
Recruiting |
NCT05490082 -
Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation
|
Phase 3 | |
Recruiting |
NCT04429360 -
What is the Effect of Prolapse Surgery on Voiding?
|
||
Completed |
NCT03991429 -
Brain Imaging in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05182853 -
Voiding Disorders in Children After Sacrococcygeal Teratoma Resection
|
||
Completed |
NCT05941260 -
Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics
|
||
Completed |
NCT03390790 -
Lidocaine for Pain After Urodynamic Testing
|
Phase 4 | |
Completed |
NCT04928716 -
Multiple Sclerosis and Voiding Symptoms: How to Assess?
|
||
Completed |
NCT04064619 -
Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms
|
N/A | |
Not yet recruiting |
NCT05240456 -
Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children
|
Phase 1/Phase 2 | |
Recruiting |
NCT03293771 -
Transgender Post-reassignment Urogynecologic Measures and Perceptions
|
||
Completed |
NCT03631160 -
Effect of Transcutaneous Acupoint Electrical Stimulation on Postoperative Spontaneous Voiding for Laparoscopic Patients
|
N/A | |
Completed |
NCT05295823 -
Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound
|
N/A | |
Completed |
NCT04570605 -
Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population
|
N/A |